| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |